Prostate cancer in Slovakia: last decade overview

Area of Science:

• Oncology
• Public Health
• Health Economics

Background:

• Prostate cancer presents a significant global health challenge, with notable increases in incidence observed in Slovakia.
• The rising number of prostate cancer cases in Slovakia necessitates a comprehensive understanding of its epidemiological, economic, and clinical dimensions.

Purpose of the Study:

• To provide a detailed overview of the prostate cancer burden in Slovakia.
• To analyze epidemiological trends, economic impact, diagnostic methods, and treatment modalities for prostate cancer in Slovakia.

Main Methods:

• A retrospective analysis of Slovak health databases (National Cancer Registry, hospital records, insurance claims) from 2009-2022.
• Evaluation of prostate cancer burden using incidence, prevalence, and mortality rates.
• Economic analysis encompassing direct and indirect costs, including healthcare expenditures and productivity loss.

Main Results:

• A consistent rise in prostate cancer incidence, particularly in men over 50, and a moderate increase in mortality rates were observed in Slovakia.
• Substantial direct and indirect economic costs associated with prostate cancer were identified, driven by advanced treatments and lost productivity.
• Improvements in diagnostic methods, including increased use of advanced imaging, were noted over the study period.

Conclusions:

• The growing burden of prostate cancer in Slovakia, marked by increasing incidence and economic costs, poses significant challenges to the healthcare system.
• Enhanced access to effective diagnostics and treatments, alongside robust health policies and public awareness initiatives, is essential for mitigating prostate cancer's impact.
• This study offers critical insights for Slovak policymakers and healthcare providers to develop targeted strategies for prostate cancer management.